HPD (HPB and Liver Transplant Surgery Padova)

Liver resection for non colorectal mets 🫧 biology biology biology! 🧬 Survival depends on indication 🦓 NET and GIST after TKI best ✋ Pancreas and UpperGI ONLY in extremely selected oligo and liver-only #fig0005" target="_blank" rel="nofollow noopener">sciencedirect.com/science/articl…

Congratulations @Ricc_Pellegrini and @CUpancreas team !!!

TRANSPLANT BENEFIT IN CRLM: OUR PAPER, NOW WITH EDITORIAL INSIGHT Honoured to see our paper in Liver Transplantation, accompanied by an editorial emphasising its importance and practical implications [1]. Our study [2] provides the first real-world external validation of the TransMet trial criteria for unresectable colorectal liver metastases, demonstrating that the survival benefit observed in the trial is reproducible outside the trial setting and quantifying the transplant advantage in a clinically meaningful manner. The editorial emphasises several key points raised by our work: the importance of external validation, the need for refined biological selection, the implications for allocation policy, and the significance of multidisciplinary referral and decision-making in this evolving field. I am grateful to all co-authors and collaborators for their valuable contributions to this significant step forward in transplant oncology. [1]journals.lww.com/lt/fulltext/99… [2]journals.lww.com/lt/fulltext/99… #LiverTransplantation #TransplantOncology #CRLM #TransMet #LiverTransplant #ColorectalLiverMetastases #SurgicalOncology #Research

Benchmarking the real-world transplant benefit in unresectable colorectal liver metastases: A preliminary external validity assessment of the TransMet trial 🎓🎓🎓 journals.lww.com/lt/abstract/99…

Happy to have contributed to #ILTSCC2026 with our chief prof. Cillo !!!

Management across the pancreatic adenocarcinoma continuum 🧬 from precursors to metastases 💥 Honored to be part of this panel surrounded by mentors and 🔝experts And happy to meet again old friends … #SSO2026 thank you for the magic 🪄

A pleasure to welcome Prof. Kuirong Jiang and Dr. Zipeng Lu from Nanjing 🇨🇳, a highly renowned center for pancreatic surgery, to Padova. Valuable scientific exchange in the operating room 🏥— and equally enjoyable moments shared beyond it 🍕🫱🏻‍🫲🏼

Another super visiting professorship at @UniPadova 🎓 with Prof. Kuirong Jiang and Dr. Zipeng Lu from Nanjing 🇨🇳 Exchange. Learn. Evolve!

Fantastic guest from @snuh_official 🇰🇷 Dr Ass Prof Hyesol Jung 👩‍⚕️ lecturing about learning curve in robot 🤖 pancreatoduodenectomy Always a great chance to enrich our knowledge and expand the borders of our collaborations! 🤝🏆🤝

We are delighted to welcome Dr. @alemarche055 to @UniPadova 🔴🔴 🥇It is an honor to have him join our team. He brings outstanding surgical expertise, scientific rigor, and great enthusiasm. 💥 We look forward to the impact he will make on our patients, research, and academia

Congratulations 🎉🎈🍾 to our new specialists in General Surgery !!! After completing 5️⃣ unforgettable years at @HPDsurgery @UniPadova 🎓 it’s time to thank you and celebrate you!

Thank you @BjsOpen 🟢🟢 for selecting our manuscript on the evolving concept of conversion surgery in HPB surgery as one of the best 🥇from 2025!!!

The first robot assisted - machine perfusion integrated liver transplant surgery in Padova has been successfully performed! 🤖 The program is ongoing since October 2025

@Gio_Marchegiani @MarcBesselink Thank you 😊 @MarcBesselink for coming to Padova! Always a pleasure to have you with us!

The one and only @MarcBesselink 🇳🇱 with a spectacular lecture on how to make pancreas science 🧬 evolve and build evidence via collaborative research 🔬… alone we go fast but together we go far!

🔴 An intense 2 days at @UniPadova for the first historical edition of WIRSUNG conference 🖌️ Infront of the original copperplate of Wirsung himself we had a full house with more than 250 participants on site and online And guess who was 👀 the guest of honor…

A new paper from the @ISGPS_news which will significantly impact clinical practice! Check it out here ⤵️⤵️⤵️

What's the best treatment option for oligometastatic (liver only) #pancreas #cancer after 1st libe chemo selection!? Thanks @BioMedCentral cancer for publishing our protocol 🔗 ⤵️ 💪

STILL THE LANCET… Once again, The Lancet gives voice to our work. Our reply [1] to two comment letters on our original Correspondence on Gaza’s healthocide [2] has just been published. This is not an academic exercise. In this response, we reiterate a point that is now even more urgent: scientific and medical societies must break their silence, with greater clarity and responsibility. Silence is not neutral and, over time, it becomes complicity. But we also add something more, looking ahead. If the Palestinian health-care system is not rapidly and effectively restored, the killing will not end when the bombs stop. It will continue quietly: through treatable infections, unmanaged trauma, undiagnosed cancers, and unassisted childbirth. This is why we explicitly speak of HEALTHOGENESIS. Denunciation alone is not enough; we must rebuild the conditions that make care possible. Functioning hospitals, trained health-care workers, medicines, supply chains, and professional dignity. Medicine, when it remains faithful to its oldest and deepest tradition, cannot look away. And today, more than ever, remaining silent means losing the last chance to save lives. [1]thelancet.com/journals/lance… [2]thelancet.com/journals/lance…

Celiac axis stenosis 🕵️‍♀️ the unknonw risk factors for additional morbidity after a Whipple 🌵 CAS incidence 16% in 1.7k cases 🚨 Grade B/C associated bile leak, liver perfusion failure, gastric ischemia 🔎 Preop diagnosis is key, treatment debatable journals.lww.com/annalsofsurger…

Integrated multidisciplinary approach 🧩 to pancreatic diseases 𝗪𝗜𝗥𝗦𝗨𝗡𝗚 2⃣0⃣2⃣6⃣ offers a comprehensive and forward-looking view of pancreatic diseases through a multidisciplinary lens, bringing together leading voices in research and clinical care More than a congress❗️